RTOG 0131: Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligodendrogliomas: Relationship between 1p/19q status and progression-free survival
Article
Vogelbaum, MA, Berkey, B, Peereboom, D et al. (2006). RTOG 0131: Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligodendrogliomas: Relationship between 1p/19q status and progression-free survival
. JOURNAL OF CLINICAL ONCOLOGY, 24(18_suppl), 1517-1517. 10.1200/jco.2006.24.18_suppl.1517
Vogelbaum, MA, Berkey, B, Peereboom, D et al. (2006). RTOG 0131: Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligodendrogliomas: Relationship between 1p/19q status and progression-free survival
. JOURNAL OF CLINICAL ONCOLOGY, 24(18_suppl), 1517-1517. 10.1200/jco.2006.24.18_suppl.1517